SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LORD ERNIE who wrote (692)9/19/1999 6:32:00 AM
From: Bart Goemaere  Read Replies (3) of 857
 
Hi there,

Just back from an incredible holiday in France and Italy.
At this moment I am processing all the information I got
from Hemispherx. The entire interview took about three hours
and a half. I had ten pages of questions for Dr. Carter.
The interview was taped so at this moment I am putting everything on paper.

The idea was to go to HEB with a negative mind set.
The general conclusion I got from the interview and wandering through paperwork was that Asensio does not have
a foot to stand on. I expect approval or disapproval from the EMEA at the end of this year/beginning of next year.
(Hoping for an approval, data looks good).

I have made an financial evaluation of the company and with
approval the worst case value of the company lies around
74 dollar. If an 80% chance exists of approval then the value of HEB should be 59.2 dollar.

Conclusion : I have increased my HEB position and have buying orders at the lower 6 level.

Need any info ? Can always telephone me of course !

Nice day !!!

Bart
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext